Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Charles Nicholas Serhan, Ph.D.

Co-Author

This page shows the publications co-authored by Charles Serhan and Yee-Ping Sun.
Connection Strength

1.276
  1. Anti-inflammatory and pro-resolving properties of benzo-lipoxin A(4) analogs. Prostaglandins Leukot Essent Fatty Acids. 2009 Nov-Dec; 81(5-6):357-66.
    View in: PubMed
    Score: 0.420
  2. Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. J Biol Chem. 2007 Mar 30; 282(13):9323-9334.
    View in: PubMed
    Score: 0.347
  3. Ajulemic acid, a synthetic cannabinoid, increases formation of the endogenous proresolving and anti-inflammatory eicosanoid, lipoxin A4. FASEB J. 2009 May; 23(5):1503-9.
    View in: PubMed
    Score: 0.099
  4. Design and synthesis of benzo-lipoxin A4 analogs with enhanced stability and potent anti-inflammatory properties. Bioorg Med Chem Lett. 2008 Feb 15; 18(4):1382-7.
    View in: PubMed
    Score: 0.093
  5. Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. J Immunol. 2007 Mar 15; 178(6):3912-7.
    View in: PubMed
    Score: 0.088
  6. Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression. Nat Immunol. 2006 Nov; 7(11):1209-16.
    View in: PubMed
    Score: 0.085
  7. Metabolic inactivation of resolvin E1 and stabilization of its anti-inflammatory actions. J Biol Chem. 2006 Aug 11; 281(32):22847-54.
    View in: PubMed
    Score: 0.083
  8. Identification of dual cyclooxygenase-eicosanoid oxidoreductase inhibitors: NSAIDs that inhibit PG-LX reductase/LTB(4) dehydrogenase. Biochem Biophys Res Commun. 2001 Nov 09; 288(4):868-74.
    View in: PubMed
    Score: 0.061
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.